Collegium Pharmaceutical (COLL) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $3.1 million.
- Collegium Pharmaceutical's Interest & Investment Income fell 500.0% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 4209.02%. This contributed to the annual value of $14.0 million for FY2024, which is 1049.63% down from last year.
- As of Q3 2025, Collegium Pharmaceutical's Interest & Investment Income stood at $3.1 million, which was down 500.0% from $2.4 million recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Interest & Investment Income registered a high of $4.5 million during Q3 2023, and its lowest value of $3000.0 during Q1 2021.
- Its 5-year average for Interest & Investment Income is $2.0 million, with a median of $2.2 million in 2025.
- As far as peak fluctuations go, Collegium Pharmaceutical's Interest & Investment Income plummeted by 9858.49% in 2021, and later soared by 8044000.0% in 2023.
- Collegium Pharmaceutical's Interest & Investment Income (Quarter) stood at $3000.0 in 2021, then surged by 34133.33% to $1.0 million in 2022, then surged by 318.99% to $4.3 million in 2023, then plummeted by 57.89% to $1.8 million in 2024, then soared by 71.96% to $3.1 million in 2025.
- Its Interest & Investment Income stands at $3.1 million for Q3 2025, versus $2.4 million for Q2 2025 and $2.2 million for Q1 2025.